Oversupply And Capacity Constraints Will Pressure Margins But Spur Diversification

AnalystLowTarget

Not Invested

Community Contributor

Published

13 Jul 25

n/a

AnalystLowTarget's Fair Value

n/a

5.6%

-2.0%

5.6%

-2.0%

You can edit this narrative until Jul 13 10:45 PM. Then, changes will post as Updates.

Author's Valuation

₹6516.9% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

₹651

6.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

10.21%

Chemicals revenue growth rate

0.64%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

14.18%

Calculation

₹6.44b

Earnings '28

14.55x

PE Ratio '28

₹93.68b

Market Cap '28

₹93.68b

Market Cap '28

96.44m

No. shares '28

₹971.39

Share Price '28

₹971.39 Share Price '28

Discounted to 2025 @ 14.27% p.a.

₹650.97

Fair Value '25